141 related articles for article (PubMed ID: 12424545)
21. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
22. Leukemic transformation in myelodysplastic syndrome: a review.
Yanuck MD; Saleem A
Ann Clin Lab Sci; 1991; 21(3):171-6. PubMed ID: 2064303
[TBL] [Abstract][Full Text] [Related]
23. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
24. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H
Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529
[TBL] [Abstract][Full Text] [Related]
26. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of myelodysplastic syndromes with cytokines].
Tohyama K; Ueda T; Tsutani H; Wano Y; Nakamura T
Rinsho Ketsueki; 1993 Mar; 34(3):277-82. PubMed ID: 8479078
[TBL] [Abstract][Full Text] [Related]
28. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
[TBL] [Abstract][Full Text] [Related]
29. Myelodysplastic syndrome in a patient with a unique constitutional chromosome abnormality t(2;11) (q31;p13).
Hinoda Y; Itoh H; Takahashi T; Adachi M; Tsujisaki M; Imai K; Yachi A
Int J Hematol; 1992 Aug; 56(1):95-7. PubMed ID: 1391810
[TBL] [Abstract][Full Text] [Related]
30. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and cytogenetic features of 29 cases of myelodysplastic syndrome associated with del(20q)].
Qin S; Liu SH; Bo LJ; Liu XP; Li CW; Dai Y; He GS; Shao ZH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):171-2. PubMed ID: 15079804
[TBL] [Abstract][Full Text] [Related]
32. Isochromosome i(17q) as a sole cytogenetic abnormality in a case of leukemic transformation from myelodysplastic syndrome (MDS)/myeloproliferative diseases (MPD).
Nishida H; Ueno H; Park JW; Yano T
Leuk Res; 2008 Aug; 32(8):1325-7. PubMed ID: 18164759
[No Abstract] [Full Text] [Related]
33. Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature.
Lunghi M; Casorzo L; De Paoli L; Riccomagno P; Rossi D; Gaidano G
Cancer Genet Cytogenet; 2010 Jan; 196(1):89-92. PubMed ID: 19963141
[TBL] [Abstract][Full Text] [Related]
34. [Mast cell leukemia evolved from RAEB-T (5q-syndrome) in a 12 year-old girl].
Sugita K; Kaneko T; Sekine Y; Taguchi N; Miyauchi J
Rinsho Ketsueki; 1996 May; 37(5):430-6. PubMed ID: 8691590
[TBL] [Abstract][Full Text] [Related]
35. Leukemic transformation associated with massive hyperdiploidy in myelodysplastic syndrome (MDS) with der(1;7)(q10;p10): a novel case study.
Lim G; Oh SH; Choi JR; Lee HJ; Suh JT; Yoon HJ; Lee S; Lee WI; Park TS
Leuk Res; 2010 Aug; 34(8):e208-9. PubMed ID: 20299095
[No Abstract] [Full Text] [Related]
36. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
[TBL] [Abstract][Full Text] [Related]
37. [Overt leukemia from MDS associated with marked basophilia].
Shirakawa C; Ohno M; Sugishima H; Morita S; Masaki H; Fujimoto T; Maeda Y; Irimajiri K; Horiuchi A
Rinsho Ketsueki; 1992 Aug; 33(8):1031-5. PubMed ID: 1404858
[TBL] [Abstract][Full Text] [Related]
38. Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome.
Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Murakami N; Miura O
Rinsho Ketsueki; 2003 Apr; 44(4):242-8. PubMed ID: 12784657
[TBL] [Abstract][Full Text] [Related]
39. Karyotypic analysis of bone marrow cells in pyodermic lesions associated with myelodysplastic syndrome.
Hamada T; Matsuura H; Oono T; Morizane S; Yamasaki O; Asagoe K; Yamamoto T; Tsuji K; Iwatsuki K
Arch Dermatol; 2008 May; 144(5):643-8. PubMed ID: 18490591
[TBL] [Abstract][Full Text] [Related]
40. Constitutional t(5;7)(q11;p15) rearranged to acquire monosomy 7q and trisomy 1q in a patient with myelodysplastic syndrome transforming to acute myelocytic leukemia.
Ganly P; McDonald M; Spearing R; Morris CM
Cancer Genet Cytogenet; 2004 Mar; 149(2):125-30. PubMed ID: 15036888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
